MedPath

The effects of moderate-intensity aerobic exercise interventions in people with IgA nephropathy: a Randomized Controlled Trial

Phase 1
Conditions
IgA nephropathy physical activity
IgA nephropathy
physical activity
Registration Number
TCTR20231019003
Lead Sponsor
West China Hospital of Sichuan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
70
Inclusion Criteria

IgAN confirmed by renal biopsy;
Age over 16 years old, regardless of gender;
Patients with eGFR over 15ml/min/1.73m;
Irregular exercise habits in the last year.

Exclusion Criteria

1.Other autoimmune diseases or secondary kidney diseases, such assystemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, diabetic nephropathy, cirrhosis, nephrotoxic drugs, etc.
2.Those on dialysis or those who are expected to be on dialysis within 1 year;
3.Suffering from other critical diseases such as heart failure, respiratory failure, malignant tumor, severe infection, severe trauma, mental disorders, severe dementia, etc.
4.Patients who underwent or required hormonal and/or immunosuppressant therapy within 6 months prior to this study were included;
5.Patients who cannot be followed up regularly;
6.Patients with musculoskeletal lesions;
7.pregnant or lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum creatinine at 12 months after end of the intervention Blood biochemical tests,proteinuria at 12 months after end of the intervention Urine tests
Secondary Outcome Measures
NameTimeMethod
Exercise tolerance at 12 months after end of the intervention 6 minutes walk test,Upper extremity strength at 12 months after end of the intervention hand grip,Lower extremity muscle strength at 12 months after end of the intervention sit to stand test,weight at 12 months after end of the intervention Scales,Quality of life at 12 months after end of the intervention SF-36
© Copyright 2025. All Rights Reserved by MedPath